38. Lutz ER, Wu AA, Bigelow E, Sharma R, Mo G, Soares K, Solt S, Dorman A, Wamwea A, Yager A, Laheru D, Wolfgang CL, Wa ng J, Hruban RH, Anders RA, Jaffee EM, Zheng L. Immunotherapy converts noni mmunogenic pancreatic tumors into immunogenic foci of immune regulation. Cancer immunology research. 2014a;2(7):616- 31. PMCID: PMC4082460 39. Lutz E, Kinkead H, Jaffee EM, Zheng L. Priming the Pancreatic Cancer Tumor Microenvironment for Checkpoint-inhibi tor Immunotherapy. OncoImmunology 2014b; 11:e962401. 40. Soares KC, Rucki AA, Wu AA, Olino K, Xiao Q, Chai Y, Wamwea A, Bigelow E, Lutz E, Liu L, Yao S, Anders AA, Laheru D, Wolfgang CL, Edil BH, Schulick RD, Jaffee EM, Zheng L. PD-1/PD-L1 blockade together with vaccine therapy facilitates effector T cell infiltration into pancreatic tumors. Journal of Immunotherapy 2015;38(1):1-11.